- Home
- IKNA vs CLPR Comparison
IKNA vs CLPR Comparison
Compare IKNA & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKNA
- CLPR
- Stock Information
- Founded
- IKNA 2016
- CLPR 2015
- Country
- IKNA United States
- CLPR United States
- Employees
- IKNA N/A
- CLPR N/A
- Industry
- IKNA Biotechnology: Pharmaceutical Preparations
- CLPR Real Estate Investment Trusts
- Sector
- IKNA Health Care
- CLPR Real Estate
- Exchange
- IKNA Nasdaq
- CLPR Nasdaq
- Market Cap
- IKNA 61.8M
- CLPR 57.8M
- IPO Year
- IKNA 2021
- CLPR 2017
- Fundamental
- Price
- IKNA $1.35
- CLPR $3.70
- Analyst Decision
- IKNA Strong Buy
- CLPR
- Analyst Count
- IKNA 1
- CLPR 0
- Target Price
- IKNA $4.00
- CLPR N/A
- AVG Volume (30 Days)
- IKNA 79.7K
- CLPR 100.6K
- Earning Date
- IKNA 08-07-2025
- CLPR 07-31-2025
- Dividend Yield
- IKNA N/A
- CLPR 10.16%
- EPS Growth
- IKNA N/A
- CLPR N/A
- EPS
- IKNA N/A
- CLPR N/A
- Revenue
- IKNA N/A
- CLPR $152,413,000.00
- Revenue This Year
- IKNA N/A
- CLPR N/A
- Revenue Next Year
- IKNA N/A
- CLPR N/A
- P/E Ratio
- IKNA N/A
- CLPR N/A
- Revenue Growth
- IKNA N/A
- CLPR 8.63
- 52 Week Low
- IKNA $0.97
- CLPR $3.38
- 52 Week High
- IKNA $1.94
- CLPR $7.12
- Technical
- Relative Strength Index (RSI)
- IKNA 53.36
- CLPR 43.04
- Support Level
- IKNA $1.31
- CLPR $3.60
- Resistance Level
- IKNA $1.38
- CLPR $3.95
- Average True Range (ATR)
- IKNA 0.06
- CLPR 0.13
- MACD
- IKNA -0.01
- CLPR -0.02
- Stochastic Oscillator
- IKNA 15.79
- CLPR 21.74
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.